NCT Number: NCT06883097
The purpose of this study is to compare the advantages and disadvantages of two approaches for quitting smoking among people living with HIV (PWH). Participants will complete a 24- week (~6-month) study where the Participants will be assigned to one of two smartphone apps to help with quitting smoking. Regardless of the group participants are assigned to, they will also receive a combination of nicotine replacement therapy (patches and gums) that have been shown to help people quit smoking. The main questions this study aims to answer are:
Participants will complete 5 video call visits over about 6 months. Participants will install their assigned smoking cessation app onto their phone and will be asked to use the app for the duration of the study along with their provided Nicotine Replacement Therapy (NRT) products. During the study visits, participants will meet with study staff to complete questionnaires and interviews. Participants may be asked to provide breath and saliva samples to measure the level of carbon monoxide and nicotine.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Winston-Salem, North Carolina, 27101, United States
Location status: Recruiting
Clinical Studies Coordinator
CONTACT
Principal Investigator
CONTACT
Roger Vilardaga
PRINCIPAL_INVESTIGATOR
Tobacco use has alarmingly high rates among people with Human Immunodeficiency Virus (HIV) (PWH), 43% compared with 15% in the general population. Due to the development of highly effective treatments for HIV and the resulting increased longevity among PWH, this population now loses more life years to smoking than to HIV infection itself. Novel and effective models to deliver wider reaching smoking cessation interventions for PWH are highly needed and indicated as a priority for National Institute of Health. Digital therapeutics (DTx) may be a novel, scalable, and highly available approach for engaging and treating smoking in this population. However, although DTx for smoking cessation have been shown effective in the general population, no large trial to date has examined the effectiveness of a tailored DTx for smoking cessation in PWH, and no implementation science work has examined barriers and facilitators of implementation of DTx for smoking cessation in this population.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
LTQ-H consists of 319 screens divided into: (a) HIV-tailored smoking cessation ACT skills, (b) education about tobacco dependence and treatment (USCPG), and (c) NRT psychoeducation and adherence. Content is gradually presented across 28 modules (14 education and 14 skills) that can be completed in 14 days.
Other names: a smoking cessation Digital Therapeutic (DTx)
This DTx, QuitGuide was adapted from the National Cancer Institute Smokefree.gov Initiative's QuitGuide's 5 modules have the following intervention components: (a) psychoeducation about the impact of smoking on health, (b) setting up a quit date and a quit plan, (c) selecting reasons for quitting, (d) tracking triggers and smoking habits, and (e) tips for quitting.
Other names: an evidence-based DTx designed for the general population
Time frame: Weeks 6, 12, 18, and 24
Abstinence is determined by a self-report of not smoking any cigarettes for greater than or equal to 7 days prior to Weeks 6, 12, 18, and 24 and biochemically verified by an expired carbon monoxide breath test or a cotinine level saliva test at Weeks 6, 12, 18, and 24. Criteria for the bioverification tests to be considered abstinent includes a reading of <6 parts per million using an iCOquit Smokerlyzer carbon monoxide breath test OR a cotinine level of 30 or less ng/ml using an iScreen saliva test.
If the participant does not meet both criteria of the self report of 7 or more days of abstinence plus a bioverification test below the thresholds listed above, they are not considered abstinent. As per convention, participants are assumed to be smoking if they report smoking at the time-point, cannot be reached to provide data at the time-point, fail to provide a breath sample at the time-point, or provide a breath sample at the time-point that is greater than or equal to 6 ppm.
Time frame: 6 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 7 days prior to the timepoint.
Time frame: 12 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 7 days prior to the timepoint.
Time frame: 18 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 7 days prior to the timepoint.
Time frame: 24 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 7 days prior to the timepoint.
Time frame: 6 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 30 days but < 30 days prior to the timepoint.
Time frame: 12 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 30 days prior to the timepoint.
Time frame: 18 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 30 days prior to the timepoint.
Time frame: 24 weeks
Percent of subjects in each group self-reporting no smoking at all for greater or equal to 30 days prior to the timepoint.
Time frame: 6 weeks
Change in self-reported number of cigarettes smoked per day, averaged within groups.
Time frame: 12 weeks
Change in self-reported number of cigarettes smoked per day, averaged within groups.
Time frame: 18 weeks
Change in self-reported number of cigarettes smoked per day, averaged within groups.
Time frame: 24 weeks
Change in self-reported number of cigarettes smoked per day, averaged within groups.
Time frame: 6 weeks
Average number of quit attempts self-reported per group at the specified time point. Quit attempts are defined by no smoking cigarettes at all for 24 hours or more.
Time frame: 12 weeks
Average number of quit attempts self-reported per group at the specified time point. Quit attempts are defined by no smoking cigarettes at all for 24 hours or more.
Time frame: 18 weeks
Average number of quit attempts self-reported per group at the specified time point. Quit attempts are defined by no smoking cigarettes at all for 24 hours or more.
Time frame: 24 weeks
Average number of quit attempts self-reported per group at the specified time point. Quit attempts are defined by no smoking cigarettes at all for 24 hours or more.
Time frame: 6 weeks
Average self-reported scores of acceptance of cravings on the physical sensations subscale of the Avoidance and Inflexibility Scale. Scores range from 4-20 with lower scores indicating more acceptance of smoking cravings.
Time frame: 12 weeks
Average self-reported scores of acceptance of cravings on the physical sensations subscale of the Avoidance and Inflexibility Scale. Scores range from 4-20 with lower scores indicating more acceptance of smoking cravings.
Time frame: 18 weeks
Average self-reported scores of acceptance of cravings on the physical sensations subscale of the Avoidance and Inflexibility Scale. Scores range from 4-20 with lower scores indicating more acceptance of smoking cravings.
Time frame: 24 weeks
Average self-reported scores of acceptance of cravings on the physical sensations subscale of the Avoidance and Inflexibility Scale. Scores range from 4-20 with lower scores indicating more acceptance of smoking cravings.
Time frame: Weeks 0-24
Average frequency of app use over the 24-week study period. Measured by average number of app openings.
Time frame: Weeks 0-24
Average duration of app use over the 24-week study period.
Time frame: Weeks 0-24
Average number of app modules completed over the 24-week study period.
Contact information is provided by the study sponsor or research team.
Clinical Studies Coordinator
CONTACT
Roger Vilardaga Vierra, Ph.D.
CONTACT
Wake Forest University Health Sciences
Other
Hybrid Trial of a Digital Therapeutic for Smoking Cessation Among Persons Living With HIV
Acronym: QMH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07553962
Behavior, Behavior, Addictive
Denver, Colorado, United States
View Trial DetailsNCT05038852
Behavior, Health Behavior
Houston, Texas, United States
View Trial DetailsNCT02576899
Behavior, Health Behavior
Bedford, Massachusetts, United States
View Trial DetailsNCT07710820
Behavior, Smoking
Brandon, Florida, United States
View Trial Details